Wednesday, June 13, 2012
ROCHESTER, Minn. — There is a lot of conflicting advice about prostate cancer screening. A recent U.S. Preventative Services Task Force recommendation against prostate-specific antigen testing, regardless of age, has added to men's confusion about how to protect themselves from a cancer that hits roughly 240,000 new patients every year and claims 28,000 lives.
Organizations that recommend PSA screening generally encourage the test between ages 40 and 75 and in men with a higher risk of prostate cancer, says Mayo urologist Jeffrey Karnes, M.D. "It may be a simple test but it's not a simple decision," Dr. Karnes says. "A PSA test is something you should decide after discussing it with your doctor, considering your risk factors and weighing your personal preferences."
Cancer overall is the No. 2 health threat to men. June is Men's Health Month, highlighting health issues of particular concern to men and strategies for prevention and treatment.
Dr. Karnes and other Mayo Clinic urologists are available for media interviews about prostate cancer screening strategies for men in their 40s, 50s, 60s and 70s that take into account the pros and cons of PSA testing. They're also available to talk about new gene-based prostate cancer screening tests on the horizon.
To interview Dr. Karnes or another Mayo Clinic urologist, please contact Joe Dangor in Public Affairs at 507-284-5005 or email email@example.com.
As one of the leading institutions funded by the National Cancer Institute, Mayo Clinic Cancer Center promotes basic and clinical research on the incidence, causes and progression of cancer and translates discoveries into improved methods for prevention, detection, diagnosis, prognosis and therapy.
Journalists can become a member of the Mayo Clinic News Network for the latest health, science and research news and access to video, audio, text and graphic elements that can be downloaded or embedded.
Learn more about becoming a patient at Mayo Clinic in the Patient & Visitor Guide.